EUVIMEDOntdek EUVIMED
Open access · CC BY 4.0

The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

David S Lynch iD, Charles Wade, Ludger Schöls iD, Stefanie N Hayer, Jeffrey M Gelfand, Wolfgang Köhler iD, Christa-Caroline Bergner, Paulo Victor Sgobbi de Souza, Elizabeth C Finger iD, Nicole I Wolf iD, Shanice Beerepoot iD, Jennifer L Orthmann-Murphy and 11 more

Brain Communications · 2026-07-01 · 8 (4)

DOI: 10.1093/braincomms/fcag271 ↗

At a glance

Journal article in Brain Communications, published online on 2026-07-14. Written by David S Lynch and 22 co-authors. Institution: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and NIHR University College London Hospitals Biomedical Research Centre…. 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Vigil Neuroscience, Inc.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (CSF1R-ALSP) is a rare, fatal, autosomal-dominant neurodegenerative disorder caused by pathogenic CSF1R variants and characterized by progressive cognitive, neuropsychiatric, and motor dysfunction, white matter lesions on brain imaging, and white matter demyelination, swollen axons, and pigmented glial cells on pathology. Limited data regarding clinical, biofluid or radiological biomarkers of disease severity are available, and no clinical trial endpoints have yet been validated. The objectives of this first-of-its-kind, prospective, observational natural history study were to characterize the clinical trajectory of CSF1R-ALSP and to identify and evaluate key biomarkers and clinical endpoints indicative of disease severity and progression. ILLUMINATE (NCT05020743) was a multicentre, noninterventional natural history study of adults with CSF1R-ALSP and prodromal carriers of CSF1R variants. Participants were followed for up to 36 months, with clinical assessments, fluid biomarkers and volumetric MRI assessments of brain atrophy collected at screening and every 6 months. This study was terminated early (4 June 2025). The analyses reported here include data collected through 19 February 2025. Of 53 participants, 19 were prodromal and 34 were symptomatic (11 of whom had a history of haematopoietic stem cell transplant and 23 who did not). Mean participant age was 47.8 (standard deviation, 4.5) years, and 36.4% were female. Prodromal participants remained relatively stable over 36 months, with little change in neurological function, neurodegeneration biomarkers or radiological disease burden. Impaired neurological function, MRI characteristics of CSF1R-ALSP, and elevated NfL (neurofilament light chain; neurodegeneration biomarker) and GFAP (glial fibrillary acidic protein; astrogliosis biomarker) levels were more pronounced at baseline and often showed progression over time among symptomatic participants who had not previously received haematopoietic stem cell transplant compared with participants who had previously received haematopoietic stem cell transplant. Significant correlations were observed at baseline and longitudinally between MRI measures of brain atrophy and clinical outcome measures. Based on the fluid biomarkers, MRI measures, and clinical outcome assessments evaluated here, active neurodegeneration, widespread changes visualized on brain MRI, and impaired cognitive and motor function were observed in symptomatic patients with CSF1R-ALSP. The neurological impairment can be assessed using the Montreal Cognitive Assessment and Cortical Basal ganglia Functional Scale. Our data suggest that quantification of brain atrophy using MRI volumetry is a potential biomarker of disease severity and progression in CSF1R-ALSP. It is hoped that this report will contribute to the understanding of disease progression in CSF1R-ALSP and inform future drug development.

Subjects

Author keywords

CSF1R-related leukoencephalopathyhereditary diffuse leukoencephalopathy with spheroidsleukodystrophymagnetic resonance imagingprimary microgliopathy

Authors and institutions

  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and NIHR University College London Hospitals Biomedical Research Centre, London WC1N 3BG, UK.
  • Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London WC1B 5EH, UK.
  • Department of Neurology, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tübingen University Hospital, Tübingen 72076, Germany.
  • Institute of Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg 20246, Germany.
  • UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
  • Department of Neurology, University of Leipzig Medical Centre, Leipzig 04103, Germany.

ORCID profiles: David S Lynch, Ludger Schöls, Wolfgang Köhler, Elizabeth C Finger, Nicole I Wolf, Shanice Beerepoot

Funding

  • Vigil Neuroscience, Inc

Cite

APA

Lynch, D. S., Wade, C., Schöls, L., Hayer, S. N., Gelfand, J. M., Köhler, W., Bergner, C. C., de Souza, P. V. S., Finger, E. C., Wolf, N. I., Beerepoot, S., Orthmann-Murphy, J. L., Chmiela, T., Rajagovindan, R., McLaren, D. G., Gaudreault, F., Mirescu, C., Raitcheva, D., Meier, A., …, & Wszolek, Z. K. (2026). The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Brain Communications, 8(4). https://doi.org/10.1093/braincomms/fcag271

Vancouver

Lynch DS, Wade C, Schöls L, Hayer SN, Gelfand JM, Köhler W, et al. The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Brain Communications. 2026;8(4). doi:10.1093/braincomms/fcag271

BibTeX
@article{Lynch2026,
  author = {Lynch, David S and Wade, Charles and Schöls, Ludger and Hayer, Stefanie N and Gelfand, Jeffrey M and Köhler, Wolfgang and Bergner, Christa-Caroline and de Souza, Paulo Victor Sgobbi and Finger, Elizabeth C and Wolf, Nicole I and Beerepoot, Shanice and Orthmann-Murphy, Jennifer L and Chmiela, Tomasz and Rajagovindan, Raj and McLaren, Donald G and Gaudreault, Francois and Mirescu, Christian and Raitcheva, Denitza and Meier, Andreas and Gray, David and Chavez, Juan and Kaufmann, Petra and Wszolek, Zbigniew K},
  title = {The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia},
  journal = {Brain Communications},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.1093/braincomms/fcag271}
}
Start for free →